Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain Injury

IMPORTANCE: In 2018, the combination of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase (UCH-L1) levels became the first US Food and Drug Administration–approved blood test to detect intracranial lesions after mild to moderate traumatic brain injury (MTBI). How this blood t...

Descripción completa

Detalles Bibliográficos
Autores principales: Papa, Linda, Ladde, Jay G., O’Brien, John F., Thundiyil, Josef G., Tesar, James, Leech, Stephen, Cassidy, David D., Roa, Jesus, Hunter, Christopher, Miller, Susan, Baker, Sara, Parrish, Gary A., Davison, Jillian, Van Dillen, Christine, Ralls, George A., Briscoe, Joshua, Falk, Jay L., Weber, Kurt, Giordano, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907341/
https://www.ncbi.nlm.nih.gov/pubmed/35285924
http://dx.doi.org/10.1001/jamanetworkopen.2022.1302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907341/
https://www.ncbi.nlm.nih.gov/pubmed/35285924
http://dx.doi.org/10.1001/jamanetworkopen.2022.1302

Ejemplares similares